Risk factors for poor prognosis in microinvasive adenocarcinoma of the uterine cervix (IA1 and IA2): A pooled analysis

被引:10
作者
Hou, June
Goldberg, Gary L. [1 ]
Qualls, Clifford R. [2 ]
Kuo, Dennis Y. S.
Forman, Aliza
Smith, Harriet O. [1 ]
机构
[1] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Div Gynecol Oncol, Albert Einstein Canc Ctr,Montefiore Med Ctr, Bronx, NY 10461 USA
[2] Univ New Mexico, Hlth Sci Ctr, Dept Math & Stat, Albuquerque, NM 87131 USA
关键词
Microinvasive adenocarcinoma; Cervical carcinoma; Histology; Adenocarcinoma in situ; EARLY INVASIVE ADENOCARCINOMA; STAGE-I ADENOCARCINOMA; SQUAMOUS-CELL CARCINOMAS; LYMPH-NODE METASTASES; OVARIAN METASTASES; CONE BIOPSY; INTRAEPITHELIAL NEOPLASIA; SITU; TUMORS; MANAGEMENT;
D O I
10.1016/j.ygyno.2010.11.036
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. To identify adverse risk factors for FIGO IA1 and IA2 cervical adenocarcinoma. Methods. PubMed was used to identify all microinvasive adenocarcinoma cases. Case specific data pooled for 35 "high risk" microinvasive adenocarcinoma (MIAC), defined as cases with lymph node or lymphovascular space involvement, positive surgical margins, or recurrence was compared with 478 "low risk" cases abstracted from the SEER database (1988-1997). Statistical methods included non-paired t and Fisher's Exact tests. Results. Survival for 1A1 and 1A2 MIAC is 99% and 98%, respectively. Significantly more 1A2 patients underwent aggressive radical surgery and received postoperative treatment. Parametrial involvement was rare (1/373 cases). Significantly more "high-risk" cases were of endometrioid histology (6/34 vs. 14/478, p = 0.001), whereas adenocarcinoma (p = 0.046) and mucinous (p = 0.021) tumors were observed in the "low-risk" group. Among the "high-risk" cases with at least 5 years follow-up, 1.4% has recurred or died. Conclusions. Endometrioid histology may be associated with late recurrence and worse survival in stage 1A1 and 1A2 MIAC. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:135 / 142
页数:8
相关论文
共 82 条
[1]   Unusual presentation of cervical cancer as advanced ovarian cancer [J].
Abdulhathi M.B. ;
Al-Salam S. ;
Kassis A. ;
Ghazal-Aswad S. .
Archives of Gynecology and Obstetrics, 2007, 276 (4) :387-390
[2]   ADENOCARCINOMA INSITU OF THE UTERINE CERVIX - A CLINICOPATHOLOGIC STUDY OF 36 CASES [J].
ANDERSEN, ES ;
ARFFMANN, E .
GYNECOLOGIC ONCOLOGY, 1989, 35 (01) :1-7
[3]   CLINICAL PRESENTATION AND MANAGEMENT OF STAGE-I CERVICAL ADENOCARCINOMA - A 25 YEAR EXPERIENCE [J].
ANGEL, C ;
DUBESHTER, B ;
LIN, JY .
GYNECOLOGIC ONCOLOGY, 1992, 44 (01) :71-78
[4]   The risk of nodal metastasis in early adenocarcinoma of the uterine cervix [J].
Balega, J ;
Michael, H ;
Hurteau, J ;
Moore, DH ;
Santiesteban, J ;
Sutton, GP ;
Look, KY .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2004, 14 (01) :104-109
[5]   Stage IA carcinoma of the cervix revisited [J].
Benedet, JL ;
Anderson, GH .
OBSTETRICS AND GYNECOLOGY, 1996, 87 (06) :1052-1059
[6]  
BEREK JS, 1985, OBSTET GYNECOL, V65, P46
[7]   Treatment of microinvasive adenocarcinoma of the uterine cervix: A retrospective study and review of the literature [J].
Bisseling, Karin C. H. M. ;
Bekkers, Ruud L. M. ;
Rome, Rob M. ;
Quinn, Michael A. .
GYNECOLOGIC ONCOLOGY, 2007, 107 (03) :424-430
[8]  
BRINTON LA, 1987, CANCER RES, V47, P1706
[9]  
BROWN JV, 1990, OBSTET GYNECOL, V76, P623
[10]  
BURGHARDT E, 1989, PATHOLOGY UTERINE CE, P447